Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

870
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
870
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

626
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
626
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.3K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

944
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
944
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helicobacter pylori infection and pregnancy-related issues: literature review.

Acta gastro-enterologica Belgica·2026
Same author

Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.

Acta gastro-enterologica Belgica·2025
Same author

The burden of ascites in cirrhosis.

Acta clinica Belgica·2025
Same author

Bismuth-based quadruple therapy versus standard triple therapy for the eradication of Helicobacter pylori in Belgium: a multicentre, non-blinded randomized, prospective study.

Acta gastro-enterologica Belgica·2024
Same author

Position statement on how can we can implement the Greendeal in our gastrointestinal and gastrointestinal endoscopy department in Belgium.

Acta gastro-enterologica Belgica·2024
Same author

Belgian consensus for Helicobacter pylori management 2023.

Acta gastro-enterologica Belgica·2023

Related Experiment Video

Updated: Apr 8, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

1.0K

Distal intestinal obstruction in CF patients.

J Maus, F Mana, H Reynaert

    Acta Gastro-Enterologica Belgica
    |June 30, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Distal intestinal obstruction syndrome (DIOS) is common in cystic fibrosis (CF) patients, causing bowel obstruction. Treatment focuses on laxatives, with surgery reserved for severe cases due to high risks in CF patients.

    More Related Videos

    A Mouse Model of Intestinal Partial Obstruction
    07:33

    A Mouse Model of Intestinal Partial Obstruction

    Published on: March 5, 2018

    22.9K
    Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
    07:56

    Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

    Published on: June 10, 2022

    3.4K

    Related Experiment Videos

    Last Updated: Apr 8, 2026

    Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
    04:14

    Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

    Published on: February 28, 2025

    1.0K
    A Mouse Model of Intestinal Partial Obstruction
    07:33

    A Mouse Model of Intestinal Partial Obstruction

    Published on: March 5, 2018

    22.9K
    Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
    07:56

    Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

    Published on: June 10, 2022

    3.4K

    Area of Science:

    • Gastroenterology
    • Pediatrics
    • Pulmonology

    Background:

    • Distal intestinal obstruction syndrome (DIOS) is a frequent complication in cystic fibrosis (CF) patients.
    • It involves obstruction of the terminal ileum and proximal colon by intestinal contents.

    Observation:

    • Diagnosis relies on right lower quadrant abdominal pain, a palpable mass, and radiographic signs of obstruction.
    • This article reviews three clinical cases of DIOS.

    Findings:

    • Conservative management with laxatives and enemas is the primary treatment.
    • Surgical intervention is a last resort due to significant peri- and postoperative morbidity in CF patients.

    Implications:

    • Understanding DIOS is crucial for managing CF patients.
    • Effective non-surgical management strategies can mitigate the need for high-risk surgeries.